“Treatment of relapsed/refractory CLL with Venetoclax-Rituximab during the COVID-19 pandemic: A daily-life experience in southern Italy”., Mediterr J Hematol Infect Dis, vol. 13, no. 1, p. e2021042, Jun. 2021, doi: 10.4084/MJHID.2021.042.